American Marconi Wireless News

NYSE - LSE

RBGPF	-0.87%	60.61	$
RYCEF	-0.16%	18.4	$
CMSD	0%	22.29	$
CMSC	0.22%	22.37	$
BCE	0%	23.28	$
BCC	5.16%	74.66	$
JRI	0.39%	12.67	$
RELX	-2.66%	31.18	$
RIO	-2.59%	100.08	$
NGG	-1.56%	79.44	$
VOD	-1.61%	14.3	$
GSK	-2.92%	50.67	$
AZN	-1.69%	174.93	$
BTI	-0.98%	58.91	$
BP	-2.66%	39.1	$

Featured

Rare Philippine school shooting kills three teens, wounds seven

Two students opened fire Monday inside a school in the central Philippines, a rare campus shooting that killed three teens and wounded seven others, police said.

Kenya labour minister accused over Russian forced recruitment

Erastus Mundia left Kenya on a work programme his government had arranged with Russia. He died on the battlefield in Ukraine, and his family holds Labour Minister Alfred Mutua responsible.

Last news

Trustpoint Xposure Trustpoint Xposure Establishes New York Headquarters, Positioning the AEO-Certified PR Agency at the Center of the AI Search Revolution

The only PR agency that guarantees brand placement inside AI-generated answers brings its full methodology to New York, the most competitive professional market in the world.

Acurx Pharmaceuticals (NASDAQ: ACXP) Highlights FDA's New CDI Guidance That Could Accelerate Approval Path for Ibezapolstat

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2026 / New to The Street's longtime featured biotechnology client, Acurx Pharmaceuticals, Inc. (Nasdaq:ACXP), highlighted a potentially transformative regulatory development for companies developing therapies targeting Clostridioides difficile infection (CDI), as the U.S. Food and Drug Administration finalized updated guidance that may significantly streamline the path toward approval for new CDI antibiotics.

Herbert Hoover Presidential Library and Museum to Celebrate Grand Reopening August 6, 2026

WEST BRANCH, IA / ACCESS Newswire / May 19, 2026 / The Hoover Presidential Foundation announced today the grand reopening of the newly renovated Herbert Hoover Presidential Library and Museum on Thursday, August 6, 2026, in West Branch, Iowa.

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

$6.0 million upfront with up to an additional approximately $12.0 million of potential aggregate gross proceeds upon the exercise in full of warrants.

AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform

Acquisition extends AP Technologies' vertically integrated catheter platform into nitinol and precision laser processing. Dundalk, Ireland joins the company's network of Centers of Excellence as its first European operation.

Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

Rapid advances in artificial intelligence may create new opportunities for MDCE to expand technical capability while accelerating execution across its AI platform initiatives.

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7

KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, is pleased to announce that ethics approval has been received from an independent review board, for Human Pilot Study #7 (GLP-1-H26-7) that will evaluate two oral DehydraTECH-semaglutide ("DHT-sema") compositions against Novo Nordisk's® commercially available Wegovy® tablets (the "Study").

Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer

First MVID patient enters the active treatment only extension phase after completion of randomized double-blind crossover period to evaluate longer-term safety and efficacy with liquid oral crofelemer as adjunctive treatment for MVID, an ultrarare pediatric disease with a lethal natural history and no approved therapies, requiring lifelong parenteral support (PS)

CLS Health Helps Child Born with Three Rare Conditions to Walk Normally

A case study from the Houston region's leading physician-owned healthcare group delivered a life-changing intervention for a child born with a rare combination of Moebius syndrome, Poland syndrome and severe clubfoot.

Europe's Hospital Cybersecurity Hot Zones and Top Cyber Vendors as EHR and EPR Attacks Shift From Data Theft to Care Disruption

Recent European hospital incidents, NIS2 accountability, EPR exposure, supplier concentration, and 72-hour downtime weakness are pushing buyers toward clinical-continuity cybersecurity ahead of HIMSS26 Europe

Empirical Spine Announces First Commercial LimiFlex(R) Cases at Stanford Medicine, Marking U.S. Launch of Motion-Preserving Alternative to Fusion for Degenerative Spondylolisthesis

First U.S. commercial cases establish LimiFlex as an outpatient, motion-preserving stabilization option

Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner

NEW YORK, NY / ACCESS Newswire / May 19, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing novel peptide-based therapies for stress-related neuropsychiatric disorders, today announced two strategic engagements to support the advancement of its lead candidate, PT00114. The Company has engaged Floyd Regulatory Strategic Consulting, led by regulatory affairs veteran Dr. Eric Floyd, Ph.D., MBA, as Regulatory Affairs Advisor, and DanforthHealth, a premier life science operational consulting firm, to establish institutional-grade operational processes and infrastructure. Together, these engagements reflect Protagenic's deliberate, lean operating model concentrating resources and expertise on PT00114's Phase 2 advancement while positioning the Company for long-term value creation for patients and shareholders.

Off The Hook YS To Rebrand as NextBoat and Change Ticker Symbol to "NXB"

WILMINGTON, NC / ACCESS Newswire / May 19, 2026 / Off The Hook YS Inc. (NYSE American:OTH) ("Off the Hook Yachts" or "Off the Hook" or "the Company"), a vertically integrated, AI-powered marine marketplace and one of the largest buyers and sellers of used boats in the United States, today announced that it will officially rebrand as NextBoat Inc. and change its ticker symbol from "OTH" to "NXB" on the NYSE American, effective on or about May 29, 2026.

Black Book Research Releases State of Digital Healthcare IT 2026: Norway Market Report

New report analyzes Norway's digital health infrastructure, EHR modernization, national e-health platforms, interoperability, AI, cybersecurity, municipal care technology, and healthcare IT vendor landscape through 2030

BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development

VANCOUVER, BC / ACCESS Newswire / May 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that its Semaglutide oral dissolvable film ("ODF") program has entered the active pharmaceutical development phase in collaboration with German drug development partner Gen-Plus GmbH.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 19

Purchase of own shares

Harry Styles fans to splash over £1 bn on London concerts: Barclays

Harry Styles' dozen concerts in London this summer will see fans spend more than £1.0 billion ($1.3 billion) combined on tickets and costs including accommodation and travel, Barclays forecast Tuesday.

Three killed in San Diego mosque shooting, two attackers dead

A shooting at a mosque complex in California killed three people Monday, with two suspected teenage gunmen later found dead in a car from self-inflicted gunshot wounds, police said.

After mayor's murder, Mexico battles to bring peace

The brazen murder of a small-city mayor shocked Mexico and forced President Claudia Sheinbaum to step up an offensive against all-powerful drug cartels.

Musk loses blockbuster OpenAI suit as jury says too late

A federal jury ruled Monday that Elon Musk waited too long to sue OpenAI and its co-founders, delivering a decisive victory to OpenAI CEO Sam Altman and ending one of Silicon Valley's most closely watched courtroom battles.

First attack on Arab nuclear site sends warning to Gulf, US

The first attack targeting an Arab nuclear site has sent a symbolic warning to the United Arab Emirates and its allies, even as Iran and the US remain in negotiations to end the Middle East war, analysts say.

Hantavirus-hit cruise ship docks in Rotterdam at voyage end

A cruise ship that sparked global alarm after a deadly outbreak of hantavirus docked in Rotterdam harbour Monday, with the skeleton crew facing weeks of quarantine.

Train driver charged after deadly Bangkok bus collision

The driver of a train that collided with a bus in Thailand's capital, killing eight people, has tested positive for drugs and was charged with reckless driving, police said Monday.

Encroaching world threatens India's last 'uncontacted' tribe

One of the last outsiders to make authorised visits to India's only "uncontacted" tribe says it may be time to reconnect with the isolated people -- in order to shield them from an encroaching world.

Four takeaways from Musk vs OpenAI trial

After three weeks of intense hearings,Silicon Valley's first major AI trial -- over the lawsuit filed by Elon Musk against the co-founders of OpenAI -- is nearing an end. It is expected to go to the jury on Monday.

'Staggering' Iran toll drives up global executions: Amnesty

Iran put to death over 2,150 people last year, a "staggering" increase that pushed recorded worldwide executions to their highest level since 1981, Amnesty International said Monday.

NanoViricides Announces Closing of ~$2 Million Registered Direct Offering

SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a clinical stage, leading ghttp://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&filenum=333-271706l pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses and their variants cannot escape, today announced the closing of its previously announced registered direct offering (the "Offering") of 1,333,334 million shares of common stock (or pre-funded warrants in lieu thereof), together with accompanying warrants to purchase 1,333,334 common shares (the "Offering"). The Offering was made to a single, fundamental institutional investor and priced at-the-market price of US$1.50 for each common share and accompanying whole warrant to purchase one common share. Each whole warrant has an exercise price of US$1.75 per share and will be exercisable six months from issuance and will expire in three years. The Company received aggregate gross proceeds of $2,000,001 from the Offering, before deducting placement agent fees and other related expenses.

LiberNovo 2026 Triple Launch: SE, Pro, and Maxis Deliver Dynamic Ergonomics for Every Body Type

HONG KONG, HK / ACCESS Newswire / May 18, 2026 / LiberNovo, the premium ergonomic chair brand redefining how people sit, today unveiled the full scope of its 2026 product expansion: three distinct lines engineered to bring Dynamic Ergonomics to a far wider range of users. The Omni SE, Omni Pro, and all-new Maxis series will officially launch on June 16, with deposit-based pre-orders now open to U.S. customers.

Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

DENVER, CO / ACCESS Newswire / May 18, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.

Watson's Accelerates Strategic Growth with Acquisition of Viridien Patio + Fireplace, Strengthening Southern U.S. Presence

Fire Help Center Urges Families to Have a Wildfire Plan in Place Before Memorial Day Weekend

With Oregon's 2026 wildfire season already underway and human activity responsible for 20% of the state's fires, experts warn that the holiday weekend is one of the highest-risk periods of the year.

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

FORT LAUDERDALE, FL / ACCESS Newswire / May 18, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $6.0 million, before deducting placement agent fees and other offering expenses payable by the Company.

American Marconi Wireless News - Boulevard (English)